Results 201 to 210 of about 754,759 (237)

Latest developments and future directions in dengue vaccines

Therapeutic Advances in Vaccines, 2014
USA Thisyakorn, Chule Thisyakorn
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Novel chikungunya and dengue vaccines-travel medicine applications.

Journal of Travel Medicine
Recent epidemics of dengue and chikungunya have highlighted the urgent need for vaccines to reduce the risk of infection in travellers. Given challenges tracking chikungunya outbreaks in real-time and the widespread resurgence of dengue, broader ...
Robert Steffen, David H. Hamer, Lin H Chen, E. Caumes, Colleen L. Lau   +4 more
semanticscholar   +1 more source

Dengue and severe dengue

Clinical Microbiology Reviews
SUMMARY Dengue is an acute mosquito-borne viral disease that is highly prevalent throughout the tropical world. The geographic footprint of the four dengue viruses (DENV-1 to -4) that cause this disease and their Aedes mosquito vector is expanding ...
S. Kalimuddin, Po Ying Chia, Jenny G. H. Low, E. Ooi   +3 more
semanticscholar   +1 more source

Introducing dengue vaccine: Implications for diagnosis in dengue vaccinated subjects

Vaccine, 2016
Diagnosis of dengue virus infections is complicated by preference for different diagnostic tests in different post onset days of illness and the presence of multiple serotypes leading to secondary and tertiary infections. The sensitivity of the most commonly employed diagnostic assays such as anti dengue IgM capture (MAC) ELISA and non structural ...
openaire   +2 more sources

Advancing dengue vaccine development

Science, 2017
Insights into the natural history of dengue virus infection guide vaccine ...
Mark B, Feinberg, Rafi, Ahmed
openaire   +2 more sources

Advances in dengue vaccine development

Human Vaccines, 2009
Dengue viruses are the most important arboviruses causing human disease. Expansion of the disease in recent decades to include more geographical areas of the world, an appreciation of the disease burden and market potentials have spurred a flurry of activity in the development of vaccines to combat dengue viruses.
Kanakatte, Raviprakash, Gabriel, Defang, Timothy, Burgess, Kevin, Porter   +3 more
openaire   +2 more sources

Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses.

Acta Tropica, 2018
Emerging and re-emerging viral infections transmitted by insect vectors (arthopode-borne viruses, arbovirus) are a serious threat to global public health.
José V.J. Silva, Thaísa R. R. Lopes, E. F. Oliveira-Filho, Renato As Oliveira, R. Durães-Carvalho, L. Gil   +5 more
semanticscholar   +1 more source

Vaccination for Dengue Prevention

JAMA, 2022
Laura E, Adams, Steve, Waterman, Gabriela, Paz-Bailey   +2 more
openaire   +2 more sources

DENGUE VACCINES.

The Southeast Asian journal of tropical medicine and public health, 2015
The uniqueness of the dengue viruses (DENVs) and the spectrum of disease resulting from infection have made dengue vaccine development difficult. Several vaccine candidates are currently being evaluated in clinical studies. The candidate currently at the most advanced clinical development stage, a live-attenuated tetravalent vaccine based on the ...
Usa, Thisyakorn, Chule, Thisyakorn
openaire   +1 more source

Dengue Virus Vaccine Development

2014
Dengue virus (DENV) is a significant cause of morbidity and mortality in tropical and subtropical regions, causing hundreds of millions of infections each year. Infections range from asymptomatic to a self-limited febrile illness, dengue fever (DF), to the life-threatening dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS).
Lauren E, Yauch, Sujan, Shresta
openaire   +2 more sources